Toivoa Inc: Clinical Trials

4 trials sponsored by Toivoa Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 withdrawn. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 2, Completed 1, Withdrawn 1

Follow Toivoa Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching
Sham Digital Program - General health education and interactive quizzes unrelated to depression or CBT., Toivoa-002 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching. - Hearing Disability, Depression
Not applicableNot yet recruitingToivoa Inc2002026-09-012026-09-10
Reduction of Anxiety Through Dual Treatment: Digital CBT & NBHWC Coaching
Sham Digital Program - General health education and interactive quizzes unrelated to anxiety or CBT., Toivoa-001 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching. - Hearing Disability, Anxiety
Not applicableNot yet recruitingToivoa Inc2002026-09-012026-09-14
Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Rauha® Digital Therapeutic Platform (Toivoa-004) - Long Covid, Depression
Not applicableWithdrawnToivoa Inc2026-07-012026-07-29
Exploratory Study for Toivoa-001 on Human Factors
Rauha - Anxiety Depression, Disability Physical
Not applicableCompletedToivoa Inc132024-07-112026-08-21

Conditions studied

Anxiety Disorders (2)  ·  Depression (2)  ·  Post-Acute COVID-19 Syndrome (1)

Countries

United States (3)

Top investigators

Jill Palmer (1)

Results publications

PMID 14399272, PMID 27060430, PMID 29451967, PMID 30994877, PMID 31646432, PMID 31753256, PMID 32775969, PMID 32914770, PMID 33471111, PMID 34047264, PMID 36129711, PMID 37164067

NIH funding

R43NR021082 (1)